Evaluating a Glioma Transcriptomic Signature Against a Clinical Reference Model and a Random-Signature Null Distribution: A Leakage-Controlled Internal Audit and a Survey of the Field.
- DOI
- 10.3390/diagnostics16172803
- Published
- 2026 Aug 31
- Container
- Diagnostics (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/diagnostics16172803,
title = {Evaluating a Glioma Transcriptomic Signature Against a Clinical Reference Model and a Random-Signature Null Distribution: A Leakage-Controlled Internal Audit and a Survey of the Field.},
author = {Yasar S and Yagin B and Alzakari SA and Alkhalifa AK and Al-Hashem F and Tabnjh AK},
year = {2026},
journal = {Diagnostics (Basel, Switzerland)},
doi = {10.3390/diagnostics16172803},
url = {https://doi.org/10.3390/diagnostics16172803}
}RIS
TY - JOUR TI - Evaluating a Glioma Transcriptomic Signature Against a Clinical Reference Model and a Random-Signature Null Distribution: A Leakage-Controlled Internal Audit and a Survey of the Field. AU - Yasar S AU - Yagin B AU - Alzakari SA AU - Alkhalifa AK AU - Al-Hashem F AU - Tabnjh AK PY - 2026 JO - Diagnostics (Basel, Switzerland) DO - 10.3390/diagnostics16172803 UR - https://doi.org/10.3390/diagnostics16172803 ER -
APA
S, Y., B, Y., SA, A., AK, A., F, A., & AK, T. (2026). Evaluating a Glioma Transcriptomic Signature Against a Clinical Reference Model and a Random-Signature Null Distribution: A Leakage-Controlled Internal Audit and a Survey of the Field.. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics16172803
Source records
- pubmed · retrieved 2026-09-24T21:01:53.202Z